A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain

NCT ID: NCT03213457

Last Updated: 2024-12-20

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

681 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-07-07

Study Completion Date

2023-12-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to evaluate safety and efficacy of elagolix in the management of moderate to severe endometriosis-associated pain in adult premenopausal female participants including the safety and efficacy of elagolix in combination with concomitant hormonal add-back therapy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Endometriosis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Elagolix Endometriosis associated pain Dysmenorrhea (DYS) Non-menstrual pelvic pain (NMPP) ORILISSA

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo

Placebo for elagolix administered twice daily (BID) plus placebo for estradiol/norethindrone acetate (E2/NETA) administered once daily (QD) for the 12-month placebo-controlled Treatment Period, followed by elagolix 200 mg BID plus E2/NETA 1 mg/0.5 mg QD for the remaining 36 months of the Treatment Period.

Group Type PLACEBO_COMPARATOR

Placebo for Elagolix

Intervention Type DRUG

Tablet

Placebo for E2/NETA

Intervention Type DRUG

Tablets

Elagolix / Elagolix + E2/NETA

Elagolix 200 mg BID alone for the first 6 months of the 12-month placebo-controlled Treatment Period and elagolix 200 mg BID+E2/NETA 1 mg/0.5 mg QD for the second 6 months, followed by elagolix 200 mg BID+E2/NETA 1 mg/0.5 mg QD for the remaining 36 months of the Treatment Period.

Group Type EXPERIMENTAL

Estradiol/Norethindrone Acetate

Intervention Type DRUG

Tablets

Elagolix

Intervention Type DRUG

Tablet

Elagolix + E2/NETA

Elagolix 200 mg BID + E2/NETA 1 mg/0.5 mg QD for the 12-month placebo-controlled Treatment Period, followed by elagolix 200 mg BID plus E2/NETA 1 mg/0.5 mg QD for the remaining 36 months of the Treatment Period.

Group Type EXPERIMENTAL

Estradiol/Norethindrone Acetate

Intervention Type DRUG

Tablets

Elagolix

Intervention Type DRUG

Tablet

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Estradiol/Norethindrone Acetate

Tablets

Intervention Type DRUG

Placebo for Elagolix

Tablet

Intervention Type DRUG

Elagolix

Tablet

Intervention Type DRUG

Placebo for E2/NETA

Tablets

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Activella E2/NETA ABT-620 Elagolix Sodium ORILISSA

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participant is a premenopausal female 18 to 49 years of age (inclusive) at the time of Screening.
* Participant has a documented surgical diagnosis (e.g., laparoscopy or laparotomy) of endometriosis established by visualization within 10 years prior to entry into Washout or Screening.
* Participant must agree to use only protocol specified rescue analgesics during the Screening and Treatment Periods for endometriosis-associated pain.
* Participant must have the following documented in the e-Diary during the last 35 days prior to Study Day 1:

1. At least 2 days of "moderate" or "severe" dysmenorrhea (DYS) AND either
2. At least 2 days of "moderate" or "severe" non-menstrual pelvic pain (NMPP) and an average NMPP score of at least 1.0, OR
3. At least 4 days of "moderate" or "severe" NMPP and an average NMPP score of at least 0.5.

Exclusion Criteria

* Participant has chronic pelvic pain that is not caused by endometriosis, that requires chronic analgesic therapy, which would interfere with the assessment of endometriosis-related pain.
* Participant is using any systemic corticosteroids for over 14 days within 3 months prior to Screening or is likely to require treatment with systemic corticosteroids during the course of the study. Over-the-counter and prescription topical, inhaled or intranasal corticosteroids are allowed.
* Participant has a history of any major depression or post-traumatic stress disorder (PTSD) within 2 years of the screening visit or other major psychiatric disorder at any time.
* Participant has a history of suicide attempts or answered "yes" to questions 4 or 5 on the suicidal ideation portion of the Columbia-Suicide Severity Rating Scale (C-SSRS) within the last 1 year at Screening or prior to randomization on Day 1.
* Participant has any history of osteoporosis or other metabolic bone disease or any condition that would interfere with obtaining adequate dual energy x-ray absorptiometry (DXA) measurements
* Screening DXA results of the lumbar spine (L1-L4), femoral neck or total hip bone mineral density (BMD) corresponding to less than 2.0 or more standard deviations below normal.
* Participant has either:

1. a newly diagnosed, clinically significant medical condition that requires therapeutic intervention (e.g., new onset hypertension), that has not been stabilized 30 days prior to randomization on Day 1 OR
2. a clinically significant medical condition that is anticipated to require intervention during the course of study participation (e.g., anticipated major elective surgery) OR
3. an unstable medical condition that makes the subject an unsuitable candidate for the study in the opinion of the Investigator, (including, but not limited to, uncontrolled diabetes mellitus, uncontrolled hypertension, epilepsy requiring anti-epileptic medication, unstable angina, confirmed inflammatory bowel disease, hyperprolactinemia, clinically significant infection or injury).
* Participant has any conditions contraindicated with use of E2/NETA.
Minimum Eligible Age

18 Years

Maximum Eligible Age

49 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AbbVie

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

AbbVie Inc.

Role: STUDY_DIRECTOR

AbbVie

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Central Research Associates /ID# 163087

Birmingham, Alabama, United States

Site Status

Alabama Clinical Therapeutics, LLC /ID# 145503

Birmingham, Alabama, United States

Site Status

Alabama Clinical Therapeutics, LLC /ID# 151468

Birmingham, Alabama, United States

Site Status

Southern Women's Specialists PC /ID# 148750

Fairhope, Alabama, United States

Site Status

Women's Health Alliance of Mobile /ID# 150083

Mobile, Alabama, United States

Site Status

University of South Alabama /ID# 148774

Mobile, Alabama, United States

Site Status

Mobile, Ob-Gyn, P.C. /ID# 145364

Mobile, Alabama, United States

Site Status

Mesa Obstetricians and Gynecologists /ID# 147320

Mesa, Arizona, United States

Site Status

Arizona Research Assoc /ID# 161703

Tucson, Arizona, United States

Site Status

Eclipse Clinical Research /ID# 155600

Tucson, Arizona, United States

Site Status

Unity Health- Searcy Medical Center /ID# 203674

Searcy, Arkansas, United States

Site Status

Core Healthcare Group /ID# 149321

Cerritos, California, United States

Site Status

HRC Fertility /ID# 154143

Encino, California, United States

Site Status

Glendale Adventist Medical Ctr /ID# 160530

Glendale, California, United States

Site Status

HCP Clinical Research LLC /ID# 152045

Huntington Beach, California, United States

Site Status

Alliance Research Centers /ID# 151240

Irvine, California, United States

Site Status

Long Beach Clinical Trial Serv /ID# 152428

Long Beach, California, United States

Site Status

Olympia Clinical Trials /ID# 202325

Los Angeles, California, United States

Site Status

California Medical Research As /ID# 154746

Northridge, California, United States

Site Status

Futura Research, Org /ID# 145406

Norwalk, California, United States

Site Status

Huntington Medical Foundation /ID# 154750

Pasadena, California, United States

Site Status

Northern California Research /ID# 159753

Sacramento, California, United States

Site Status

Precision Research Institute - San Diego /ID# 152557

San Diego, California, United States

Site Status

MD Strategies Research Centers /ID# 152429

San Diego, California, United States

Site Status

Alta California Medical Group /ID# 155706

Simi Valley, California, United States

Site Status

Downtown Womens Health Care /ID# 147955

Denver, Colorado, United States

Site Status

Advanced Women's Health Institute /ID# 145396

Greenwood Village, Colorado, United States

Site Status

Red Rocks OB/GYN /ID# 145325

Lakewood, Colorado, United States

Site Status

The Women's Health Group - Thornton /ID# 203707

Thornton, Colorado, United States

Site Status

James A. Simon, MD, PC /ID# 145480

Washington D.C., District of Columbia, United States

Site Status

Helix Biomedics, LLC /ID# 147108

Boynton Beach, Florida, United States

Site Status

Gulf Coast Research Group /ID# 162895

Brandon, Florida, United States

Site Status

Olympian Clinical Research /ID# 148167

Clearwater, Florida, United States

Site Status

Omega Research Maitland, LLC /ID# 145167

DeBary, Florida, United States

Site Status

KO Clinical Research, LLC /ID# 145410

Fort Lauderdale, Florida, United States

Site Status

Clinical Physiology Associates /ID# 145237

Fort Myers, Florida, United States

Site Status

Solutions Through Adv Rch /ID# 148768

Jacksonville, Florida, United States

Site Status

Vida Clinical Research /ID# 150282

Kissimmee, Florida, United States

Site Status

Axcess Medical Center /ID# 148169

Loxahatchee Groves, Florida, United States

Site Status

Genoma Research Group, Inc /ID# 152558

Miami, Florida, United States

Site Status

Vista Health Research LLC - Miami /ID# 151455

Miami, Florida, United States

Site Status

Palmetto Professional Research /ID# 153838

Miami, Florida, United States

Site Status

Precision Research Organization /ID# 145337

Miami Lakes, Florida, United States

Site Status

Ocean Blue Medical Research Center, Inc /ID# 145514

Miami Springs, Florida, United States

Site Status

Salom Tangir, LLC /ID# 148739

Miramar, Florida, United States

Site Status

Suncoast Clinical Research /ID# 145484

New Port Richey, Florida, United States

Site Status

Oncova Clinical Research, Inc. /ID# 148175

Saint Cloud, Florida, United States

Site Status

Physician Care Clin. Res., LLC /ID# 145511

Sarasota, Florida, United States

Site Status

Meridien Research - St Petersburg /ID# 145345

St. Petersburg, Florida, United States

Site Status

Treasure Coast Research /ID# 148174

Stuart, Florida, United States

Site Status

University of South Florida /ID# 145424

Tampa, Florida, United States

Site Status

Stedman Clinical Trials /ID# 152554

Tampa, Florida, United States

Site Status

Virtus Research Consultants, LLC /ID# 147101

Wellington, Florida, United States

Site Status

Comprehensive Clinical Trials /ID# 145148

West Palm Beach, Florida, United States

Site Status

Paramount Research Solutions /ID# 145226

Alpharetta, Georgia, United States

Site Status

Paramount Research Solutions /ID# 149320

Alpharetta, Georgia, United States

Site Status

Agile Clinical Research Trials /ID# 145494

Atlanta, Georgia, United States

Site Status

Atlanta Women's Research Inst /ID# 145543

Atlanta, Georgia, United States

Site Status

Apogee Women's Health Inc. /ID# 145149

College Park, Georgia, United States

Site Status

Columbus Regional Research Ins /ID# 159752

Columbus, Georgia, United States

Site Status

Meridian Clinical Research, LLC /ID# 148176

Savannah, Georgia, United States

Site Status

Atlanta Gynecology Research Institute /ID# 149322

Suwanee, Georgia, United States

Site Status

Clinical Research Prime /ID# 161724

Idaho Falls, Idaho, United States

Site Status

Womens Healthcare Assoc, DBA /ID# 148744

Idaho Falls, Idaho, United States

Site Status

Advanced Clinical Research /ID# 147086

Meridian, Idaho, United States

Site Status

Sonora Clinical Research /ID# 145541

Meridian, Idaho, United States

Site Status

Asr, Llc /Id# 161680

Nampa, Idaho, United States

Site Status

Women's Health Practice, LLC /ID# 145517

Champaign, Illinois, United States

Site Status

Affinity Clinical Research /ID# 151469

Oak Brook, Illinois, United States

Site Status

Center for Women's Research, Inc /ID# 145486

Palos Heights, Illinois, United States

Site Status

The Advanced Gynecologic Surgery Institute - Park Ridge /ID# 151459

Park Ridge, Illinois, United States

Site Status

American Health Network of Ind /ID# 167996

Avon, Indiana, United States

Site Status

Women's Health Advantage /ID# 145495

Fort Wayne, Indiana, United States

Site Status

The Iowa Clinic /ID# 145409

West Des Moines, Iowa, United States

Site Status

Womens & Family Care, LLC dba /ID# 145211

Shawnee Mission, Kansas, United States

Site Status

PRN Professional Research Network of Kansas, LLC /ID# 151463

Wichita, Kansas, United States

Site Status

Cypress Medical Research Ctr /ID# 147159

Wichita, Kansas, United States

Site Status

University of Louisville /ID# 154751

Louisville, Kentucky, United States

Site Status

Bluegrass Clinical Research /ID# 151209

Louisville, Kentucky, United States

Site Status

Clinical Trials Management, LLC - Covington /ID# 145220

Covington, Louisiana, United States

Site Status

Clinical Trials Management, LLC - Covington /ID# 145520

Covington, Louisiana, United States

Site Status

Horizon Research Group /ID# 148171

Eunice, Louisiana, United States

Site Status

Praetorian Pharmaceutical Res /ID# 145405

Marrero, Louisiana, United States

Site Status

Ochsner Baptist OB/GYN Clinic /ID# 147144

New Orleans, Louisiana, United States

Site Status

Women Under Study, LLC /ID# 151216

New Orleans, Louisiana, United States

Site Status

Women's Health Clinic /ID# 155707

Shreveport, Louisiana, United States

Site Status

Omni Fertility and Laser Insti /ID# 145532

Shreveport, Louisiana, United States

Site Status

Eastern Maine Medical Center /ID# 161681

Bangor, Maine, United States

Site Status

Univ Maryland School Medicine /ID# 151739

Baltimore, Maryland, United States

Site Status

Baltimore Suburban Health /ID# 147164

Baltimore, Maryland, United States

Site Status

Continental Clinical Solutions /ID# 152041

Towson, Maryland, United States

Site Status

NECCR Fall River LLC /ID# 145329

Fall River, Massachusetts, United States

Site Status

Genesis Clinical Research - Fall River /ID# 148573

Fall River, Massachusetts, United States

Site Status

ClinSite, LLC /ID# 145314

Ann Arbor, Michigan, United States

Site Status

Great Lakes Research Group, Inc. /ID# 145308

Bay City, Michigan, United States

Site Status

Saginaw Valley Med Res Group /ID# 145527

Saginaw, Michigan, United States

Site Status

Wayne State University Physician Group - Southfield /ID# 145431

Southfield, Michigan, United States

Site Status

Prism Research /ID# 159751

Saint Paul, Minnesota, United States

Site Status

Womens Clinic of Lincoln, P.C. /ID# 145366

Lincoln, Nebraska, United States

Site Status

Accent Clinical Trials /ID# 147109

Las Vegas, Nevada, United States

Site Status

Office of Edmond E. Pack, MD /ID# 148747

Las Vegas, Nevada, United States

Site Status

R. Garn Mabey Jr, MD Chartered /ID# 145361

Las Vegas, Nevada, United States

Site Status

Jersey Shore University Medical Center /ID# 148756

Neptune City, New Jersey, United States

Site Status

Rutgers Robert Wood Johnson /ID# 152858

New Brunswick, New Jersey, United States

Site Status

St. Joseph's Regional Medical /ID# 157759

Totowa, New Jersey, United States

Site Status

Albuquerque Clinical Trials, Inc /ID# 154747

Albuquerque, New Mexico, United States

Site Status

Bosque Women's Care /ID# 147084

Albuquerque, New Mexico, United States

Site Status

SUNY Downstate Medical Center /ID# 148749

Brooklyn, New York, United States

Site Status

Scott Research Inc. /ID# 161704

Laurelton, New York, United States

Site Status

Manhattan Medical Research /ID# 145175

New York, New York, United States

Site Status

Columbia Univ Medical Center /ID# 145334

New York, New York, United States

Site Status

Hamburg Regional Gynecology Gr /ID# 161705

Orchard Park, New York, United States

Site Status

OB.GYN Associates of WNY /ID# 161665

West Seneca, New York, United States

Site Status

PMG Research of Charlotte /ID# 145432

Charlotte, North Carolina, United States

Site Status

DJL Clinical Research, PLLC /ID# 154679

Charlotte, North Carolina, United States

Site Status

Carolina Women's Research and Wellness Center /ID# 145356

Durham, North Carolina, United States

Site Status

Unified Women's Clinical Research-Greensboro /ID# 155543

Greensboro, North Carolina, United States

Site Status

Pinewest Ob-Gyn, Inc. /ID# 151743

High Point, North Carolina, United States

Site Status

Eastern Carolina Women's Centr /ID# 145386

New Bern, North Carolina, United States

Site Status

Unified Women's Clinical Resea /ID# 145353

Raleigh, North Carolina, United States

Site Status

PMG Research of Wilmington /ID# 152555

Wilmington, North Carolina, United States

Site Status

Trinity Health Center Town /ID# 147102

Minot, North Dakota, United States

Site Status

Clinical Inquest Center Ltd /ID# 147107

Beavercreek, Ohio, United States

Site Status

CTI Clinical Research Center /ID# 145428

Cincinnati, Ohio, United States

Site Status

The Christ Hospital /ID# 149244

Cincinnati, Ohio, United States

Site Status

University of Cincinnati /ID# 145496

Cincinnati, Ohio, United States

Site Status

Univ Hosp Cleveland /ID# 148741

Cleveland, Ohio, United States

Site Status

The Ohio State University /ID# 145444

Columbus, Ohio, United States

Site Status

Aventiv Research, Inc. /ID# 145492

Columbus, Ohio, United States

Site Status

Aventiv Research, Inc. /ID# 162896

Columbus, Ohio, United States

Site Status

Wright State University & CTRA /ID# 145512

Fairborn, Ohio, United States

Site Status

University of Toledo /ID# 145403

Toledo, Ohio, United States

Site Status

Oregon Health and Science University /ID# 155705

Portland, Oregon, United States

Site Status

Main Line Fertility Center /ID# 150099

Bryn Mawr, Pennsylvania, United States

Site Status

OB/GYN Associates of Erie /ID# 157935

Erie, Pennsylvania, United States

Site Status

Penn State University and Milton S. Hershey Medical Center /ID# 145231

Hershey, Pennsylvania, United States

Site Status

University of Pennsylvania /ID# 145470

Philadelphia, Pennsylvania, United States

Site Status

Drexel Univ College of Med /ID# 149789

Philadelphia, Pennsylvania, United States

Site Status

Frontier Clinical Research /ID# 162091

Smithfield, Pennsylvania, United States

Site Status

Vista Clinical Research /ID# 148767

Columbia, South Carolina, United States

Site Status

University Medical Group /ID# 148777

Greenville, South Carolina, United States

Site Status

Venus Gynecology, LLC /ID# 145336

Myrtle Beach, South Carolina, United States

Site Status

James T. Martin, Jr., MD., Obs /ID# 148755

North Charleston, South Carolina, United States

Site Status

Palmetto Clinical Research /ID# 150992

Summerville, South Carolina, United States

Site Status

Brown Clinic, PLLP /ID# 154372

Watertown, South Dakota, United States

Site Status

Holston Medical Group /ID# 145449

Bristol, Tennessee, United States

Site Status

Chattanooga Medical Research /ID# 145184

Chattanooga, Tennessee, United States

Site Status

WR-ClinSearch /ID# 145205

Chattanooga, Tennessee, United States

Site Status

The Jackson Clinic, PA /ID# 145303

Jackson, Tennessee, United States

Site Status

Research Memphis Associates, LLC /ID# 150100

Memphis, Tennessee, United States

Site Status

Access Clinical Trials, Inc. /ID# 145224

Nashville, Tennessee, United States

Site Status

Lotus Gynecology /ID# 148479

Austin, Texas, United States

Site Status

AA (Austin Area) ObGyn PLLC /ID# 205696

Austin, Texas, United States

Site Status

Sirius Clinical Research, LLC /ID# 154749

Austin, Texas, United States

Site Status

Gadolin Research, LLC /ID# 201383

Beaumont, Texas, United States

Site Status

Center for Assisted Reprod. /ID# 154748

Bedford, Texas, United States

Site Status

Texas Health Presbyterian Hosp /ID# 150098

Dallas, Texas, United States

Site Status

UT Southwestern Medical Center /ID# 145201

Dallas, Texas, United States

Site Status

Baylor Scott & White /ID# 170430

Fort Worth, Texas, United States

Site Status

Signature Gyn Services /ID# 145534

Fort Worth, Texas, United States

Site Status

Willowbend Health and Wellness - Frisco /ID# 145245

Frisco, Texas, United States

Site Status

Next Innovative Clinical Research /ID# 203863

Houston, Texas, United States

Site Status

Advances in Health, Inc. /ID# 145425

Houston, Texas, United States

Site Status

Houston Methodist Hospital /ID# 170586

Houston, Texas, United States

Site Status

Precision Research Institute - Houston /ID# 154370

Houston, Texas, United States

Site Status

The Woman's Hospital of Texas /ID# 145316

Houston, Texas, United States

Site Status

Centex Studies, Inc /ID# 148776

Houston, Texas, United States

Site Status

FMC Science /ID# 150981

Lampasas, Texas, United States

Site Status

Clinical Trials of Texas, Inc /ID# 147100

San Antonio, Texas, United States

Site Status

VIP Trials /ID# 151745

San Antonio, Texas, United States

Site Status

Discovery Clinical Trials-San Antonio /ID# 145363

San Antonio, Texas, United States

Site Status

Houston Ctr for Clin Research /ID# 148799

Sugar Land, Texas, United States

Site Status

Center of Reproductive Medicin /ID# 145467

Webster, Texas, United States

Site Status

Corner Canyon Obstetrics and G /ID# 145519

Draper, Utah, United States

Site Status

Tanner Clinic /ID# 148786

Layton, Utah, United States

Site Status

Revere Health /ID# 145540

Pleasant Grove, Utah, United States

Site Status

Southampton Women's Health /ID# 151691

Franklin, Virginia, United States

Site Status

Health Research of Hampton Roads, Inc. (HRHR) /ID# 156477

Newport News, Virginia, United States

Site Status

Clinical Research Partners, LL /ID# 145392

North Chesterfield, Virginia, United States

Site Status

Clinical Research Partners, LL /ID# 145416

North Chesterfield, Virginia, United States

Site Status

Clinical Trials Virginia, Inc. /ID# 145430

Richmond, Virginia, United States

Site Status

Alliance Womens Health /ID# 148770

Richmond, Virginia, United States

Site Status

Tidewater Clinical Research /ID# 145397

Virginia Beach, Virginia, United States

Site Status

Clinical Research Adv, Inc. /ID# 149257

Puyallup, Washington, United States

Site Status

Virginia Mason Medical Center /ID# 145387

Seattle, Washington, United States

Site Status

Seattle Women's Health, Research, Gynecology /ID# 145341

Seattle, Washington, United States

Site Status

North Spokane Women's Health /ID# 145382

Spokane, Washington, United States

Site Status

Madigan Army Medical Center /ID# 145186

Tacoma, Washington, United States

Site Status

Strand Clinic /ID# 152582

St. John's, Newfoundland and Labrador, Canada

Site Status

Medicor Research Inc /ID# 151453

Greater Sudbury, Ontario, Canada

Site Status

The Ottawa Hospital /ID# 148927

Ottawa, Ontario, Canada

Site Status

Mount Sinai Hosp.-Toronto /ID# 148972

Toronto, Ontario, Canada

Site Status

Victory Reproductive Care /ID# 149016

Windsor, Ontario, Canada

Site Status

Puerto Rico Medical Research /ID# 152040

Ponce, , Puerto Rico

Site Status

Clinical Research Puerto Rico /ID# 149018

San Juan, , Puerto Rico

Site Status

Rodriguez-Ginorio, San Juan /ID# 145545

San Juan, , Puerto Rico

Site Status

School of Medicine University of Puerto Rico-Medical Science Campus /ID# 145546

San Juan, , Puerto Rico

Site Status

Countries

Review the countries where the study has at least one active or historical site.

American Samoa United States Canada Puerto Rico

References

Explore related publications, articles, or registry entries linked to this study.

Watts NB, Binkley N, Owens CD, Al-Hendy A, Puscheck EE, Shebley M, Schlaff WD, Simon JA. Bone Mineral Density Changes Associated With Pregnancy, Lactation, and Medical Treatments in Premenopausal Women and Effects Later in Life. J Womens Health (Larchmt). 2021 Oct;30(10):1416-1430. doi: 10.1089/jwh.2020.8989. Epub 2021 Aug 25.

Reference Type DERIVED
PMID: 34435897 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

M14-702

Identifier Type: -

Identifier Source: org_study_id